INDEPENDENT CITIZENS OVERSIGHT COMMITTEE (“ICOC”)
TO THE CALIFORNIA INSTITUTE FOR REGENERATIVE MEDICINE (CIRM)

Organized Pursuant To Government Code section 11346.5(a)(17)
and
The CALIFORNIA STEM CELL RESEARCH AND CURES ACT

EXECUTIVE PRESENTATIONS

5. Chairman’s Report.
6. President’s Report.

ACTION ITEMS

7. Consideration of appointment of new scientific members for Grants Working Group.
8. Consideration of appointment of new member to Standards Working Group.
9. Consideration of update from Standards Working Group and a regulatory amendment authorizing a procedure for petitioning the ICOC to designate stem cell lines derived before November 2006 as acceptably derived for use in CIRM-funded research.

        a.  Attachment 1: Draft Language for “Grandfathering” Provision
        b.  Attachment 2: Recommended Language for Regulatory Amendment

10. Consideration of definition for “California Supplier”
          a. Background Memo
11. Consideration of recommendations from Grants Working Group on New Faculty Awards II Applications.

CLOSED SESSION

  12.
         a. Discussion of confidential intellectual property or work product and prepublication,

              confidential scientific research or data relating to New Faculty Awards II applications. (Health

               & Safety Code 125290.30(d) (3) (B) and (C)).

         b. Discussion of Personnel (Government Code section 11126, subdivision (a); Health & Safety Code

    section 125290.30(d) (3) (D)).

  13. Public report of any action taken, if necessary, during closed session.

***It is expected that most of the items below this will occur on August 13th 2008***

OPEN SESSION

14. Consideration of CIRM Loan Policy.
         a. CIRM Loan Policy
15. Consideration of names for CIRM funded Major Facilities.
16. Consideration of recommendations on RFA applicant policies.
17. Consideration of Policy Regarding Extraordinary Petitions for ICOC Consideration of Applications for Funding.
18. Consideration of update from Legislative Subcommittee.

    a. AB 2296 Bill Analysis
    b.AB 2296 Amended Bill
    c. AB 2381 Bill Amendments
    d. AB 2381 Bill As Amended
    e. SB 1565 Bill As Amended
    f.  SB 1565 Bill Analysis
    g. Letter from CIRM to Senator Kuehl 07/10/08
    h. Letter from CIRM to Senator Kuehl 07/28/08
    i. Letter from Senator Kuehl 08/05/08
    j.  Letter from CIRM to Senator Kuehl 08/06/08

19. Consideration of annual report on CIRM contracts and interagency agreements.
20. Consideration of update on gifts to CIRM.

DISCUSSION ITEMS

21. Public comment. The Committee will accept public testimony on any matter under its jurisdiction that is not on the agenda, but the Committee cannot act on any such matter at this meeting.

THE ORDER OF BUSINESS MAY BE CHANGED WITHOUT NOTICE.
Notice is hereby given that the order of consideration of matters on this agenda may be changed without prior notice.

**NOTICE**

The California Institute for Regenerative Medicine and its Independent Citizens Oversight Committee, and any subcommittees thereof, comply with the Americans with Disabilities Act (ADA) by ensuring that the meeting facilities are accessible to persons with disabilities, and providing that this notice and information given to the Members of the Committee is available to the public in appropriate alternative formats when requested. If you need further assistance, including disability-related modifications or accommodations, you may contact Melissa King at the California Institute for Regenerative Medicine at 415-396-9100 no later than the day prior to the meeting.

Questions or requests for additional information prior to the Independent Citizens Oversight Committee meeting may be referred to Melissa King at the California Institute for Regenerative Medicine at mking@cirm.ca.gov or 415-396-9100.

This meeting agenda is also available on the website for the California Institute for Regenerative Medicine at https://www.cirm.ca.gov.